Suchergebnisse - "Meyer-Rath, Gesine"

PubPharm (102)

21

The role of modelling and analytics in South African COVID-19 planning and budgeting

enthalten in: PLOS global public health | 2023

von Meyer-Rath, G. | Hounsell, R. | Pulliam, J. | +4

22

The National COVID-19 Epi Model (NCEM) : Estimating cases, admissions and deaths for the first wave of COVID-19 in South Africa

enthalten in: PLOS global public health | 2023

von Silal, S. | Pulliam, J. | Meyer-Rath, G. | +7

23

Integration of point-of-care screening for type 2 diabetes mellitus and hypertension with COVID-19 rapid antigen screening in Johannesburg, South Africa

enthalten in: PloS one | 2023

von Brennan, A. | Vetter, B. | Majam, M. | +6

24

Differential in-hospital mortality and intensive care treatment over time : Informing hospital pathways for modelling COVID-19 in South Africa

enthalten in: PLOS global public health | 2023

von Jamieson, L. | Van Schalkwyk, C. | Nichols, B. | +7

25

What will it take for an injectable ARV to change the face of the HIV epidemic in high‐prevalence countries? Considerations regarding drug costs and operations

enthalten in: Journal of the International AIDS Society | 2023

von Meyer‐Rath, G. | Jamieson, L. | Pillay, Y.

26

The costs of interventions for type 2 diabetes mellitus, hypertension and cardiovascular disease in South Africa - a systematic literature review

enthalten in: BMC public health | 2022

von Masuku, S. | Lekodeba, N. | Meyer-Rath, G.

27

The costs of interventions for type 2 diabetes mellitus, hypertension and cardiovascular disease in South Africa – a systematic literature review

enthalten in: BMC public health | 2022

von Masuku, S. | Lekodeba, N. | Meyer-Rath, G.

28

The costs of interventions for type 2 diabetes mellitus, hypertension and cardiovascular disease in South Africa – a systematic literature review

enthalten in: BMC public health | 2022

von Masuku, S. | Lekodeba, N. | Meyer-Rath, G.

29

Relative cost-effectiveness of long-acting injectable cabotegravir versus oral pre-exposure prophylaxis in South Africa based on the HPTN 083 and HPTN 084 trials : a modelled economic evaluation and threshold analysis

enthalten in: The lancet. HIV | 2022

von Jamieson, L. | Johnson, L. | Nichols, B. | +4

CommentIn: Lancet HIV. 2022 Dec;9(12):e814-e815. - PMID 36356602

30

Cost-effectiveness of remdesivir and dexamethasone for COVID-19 treatment in South Africa

enthalten in: bioRxiv.org | 2022

von Jo, Y. | Jamieson, L. | Edoka, I. | +7